Business
This new weight-loss medicine is flying off the shelves – The Australian Financial Review
Novo Nordisk, best-known for diabetes treatments, is using Wegovy to treat the global obesity epidemic – a related chronic ailment…
Patients are flocking to the first new obesity medicine to reach the market in years, boosting returns for drug maker Novo Nordisk.
In a field starved for options, demand is exceeding supply for Wegovy, a weekly injection launched in June that dampens patients…
Continue Reading